Moreover, changes in genetic frequencies (mutation or copy number change) of the 25 genes were very low in gliomas, the genetic variation of TP53 was 39%, that of RB1 was 5%, and that of ACACA was 2%, and the rest were less than 1% (Supplementary Figure 7). This evidence concerns the gene RB1 and central nervous system cancer.